2136287-65-3

Basic information

• Product Name: 3,4-difluoro-2-((phenylthio)methyl)benzoic acid
• CAS NO: 2136287-65-3
• Molecular Weight: 280.295
• Mol File: 2136287-65-3.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 413.2±45.0 °C(Predicted)
• Density: 1.39±0.1 g/cm3(Predicted)
• CAS DataBase Reference: 3,4-difluoro-2-((phenylthio)methyl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-difluoro-2-((phenylthio)methyl)benzoic acid(2136287-65-3)
• EPA Substance Registry System: 3,4-difluoro-2-((phenylthio)methyl)benzoic acid(2136287-65-3)

Safety Data

• Hazardous Substances Data: 2136287-65-3(Hazardous Substances Data)

Usage

General Description

3,4-difluoro-2-((phenylthio)methyl)benzoic acid is a chemical compound with the molecular formula C14H10F2O2S. It is a benzoic acid derivative containing two fluorine atoms at the 3 and 4 positions, as well as a phenylthio group attached to the 2 position of the benzoic acid ring. 3,4-difluoro-2-((phenylthio)methyl)benzoic acid has potential applications in pharmaceuticals and agrochemicals due to its unique structure and properties. It may be used as a building block in organic synthesis to create new molecules with specific biological activities. Additionally, its fluorinated and thiol-containing moieties make it a potential candidate for studying fluorine and sulfur chemistry in biological systems. Further research and development of 3,4-difluoro-2-((phenylthio)methyl)benzoic acid may lead to the discovery of novel drug candidates or agrochemicals with improved efficacy and selectivity.

Upstream product

• 348-61-8 1-bromo-3,4-difluorobenzene 
• 930-69-8 sodium thiophenolate 
• 157652-31-8 3,4-difluoro-2-methyl benzoic acid 
• 108-98-5 thiophenol 
• 160775-14-4 3,4-difluoro-2-methylbenzoic acid methyl ester 
• 3828-49-7 1,2-difluoro-3-methyl-benzene 
• 847502-81-2 1-bromo-3,4-difluoro-2-methyl-benzene 
• 847502-83-4 3,4-difluoro-2-methylbenzonitrile 
• 130286-84-9 N,N-diethyl-3,4-difluorobenzamide 
• 882-33-7 diphenyldisulfane 
• 1807193-48-1 1-bromo-2-(bromomethyl)-3,4-difluorobenzene 
• 651326-72-6 (6-bromo-2,3-difluorophenyl)methanol 
• 124-38-9 carbon dioxide 

Downstream Products

• 2136287-66-4 7,8-difluoro-6,11-dihydrodibenzo[b,e]thiazepin-11-one 
• 1985607-83-7 7,8-difluoro-6,11-dihydrodibenzo[b,e]thiazepine-11-ol 
• 1985605-59-1 (R)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-7-hydroxy-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione 

Relevant articles and documents

Preparation method of sulfur-containing hetero-seven-membered ring compound

The invention relates to a preparation method of a sulfur-containing hetero-seven-membered ring compound. The method comprises the following steps: carrying out halogenation reaction, nucleophilic substitution, acylation, cyclization, reduction and the li

Method for preparing baloxavir intermediate and intermediate obtained by method

The invention belongs to the technical field of chemical synthesis, and provides a method for preparing a balosavir intermediate. The method comprises the following steps: (1) methylating 3,4-difluorobromobenzene to obtain a compound A-1; (2) reacting the compound A-1 with a Grignard reagent, then introducing carbon dioxide gas for reaction, and adding acid for acidification to obtain a compound A-2; (3) brominating the compound A-2 to obtain a compound A-3; (4) adding diphenyl disulfide and a reducing agent 1 into THF, dropwise adding methanol, dropwise adding the compound A-3, and reacting to obtain a compound A-4; (5) carrying out ring closing reaction on the compound A-4 in polyphosphoric acid to obtain a compound A-5; and (6) reducing the compound A-5 into alcohol by adopting a reducing agent 2 to obtain a compound A-6. According to the method, highly toxic and foul thiophenol is prevented from being used while expensive reagents are prevented from being used, so that the processcost is reduced. The invention also provides an intermediate compound prepared by the method.

Preparation method of baloxavir intermediate

The invention relates to a preparation method of a baloxavir intermediate and belongs to the field of medicinal chemistry. With the compound (A) as an initial raw material, the method includes a halogenation reaction, a Grignard reaction, a halogenation r